PBS
New listings
The Health Minister has highlighted new PBS listings from Monday, March 1, including drugs to treat MS, asthma and diabetes From March 1, Zeposia and Atecture Breezhaler will be listed …
Heading the charts
What are the ten most commonly dispensed, and the ten most expensive drugs on the PBS at the moment? A drug used to treat eye conditions such as macular degeneration …
Targeting secondary cardiovascular events
Low-dose Xarelto has been listed on the PBS in combination with aspirin, for the prevention of major cardiovascular events in high-risk patients While pharmacists have been familiar with Xarelto (rivaroxaban) …
Keeping the costs down
Questions over the price of private prescriptions due to “commercial decisions by the pharmacist” as Senate tackles the question of medicine shortages Federal Senators questioned Department of Health officials on …
New treatment options approved
New medicine options approved after problems hit supply of depression treatments The Therapeutic Goods Administration has approved new overseas options after problems were revealed regarding the availability of a couple …
1945: Peace and the PBS
Pharmacy leaders welcomed the end of World War II in our August 1945 issue, but a war of words was building over the government’s Pharmaceutical Benefits bill Pharmacy leaders expressed …
The price disclosure roadmap
The next batch of medicines to undergo price disclosure reductions has been revealed The PBS has released the list of medicines that are to be included in the October 2020 …
New advice on combinations
PBS issues new claiming advice on opioid combinations as listing changes take effect From yesterday (1 June 2020) Pharmaceutical Benefits Scheme (PBS) listings have changed for opioid products. The PBS …
Built-in flexibility
Government moves to temporarily ease PBS authority restrictions during pandemic crisis The Australian Government is implementing a temporary measure that allows flexibility around PBS restrictions for eligible PBS medicines to …
Getting the right agreement
In the second of a series, Kim Brotherson, Pharmacy 777 Managing Director, discusses five crucial objectives for the 7CPA In the first of this series, we looked at the scene …
A flawed agenda
The Government’s current narrow focus on 60-day dispensing and the $1 discount is doing little to ease fears that universal access to medicines is under threat from its determination to …
Come join the fight
Guild issues call to members to join it in fighting the Government’s 60-day scripts push and advocating for permanent continued dispensing by pharmacists The Pharmacy Guild of Australia says it …